Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma
Stopped early · Not applicable
Conditions studied: Brain and Central Nervous System Tumors, Musculoskeletal Complications
In brief
RATIONALE: Testosterone gel may be effective in preventing or lessening muscle weakness caused by steroid therapy in men receiving glucocorticoids for newly diagnosed high-grade glioma. PURPOSE: This randomized clinical trial is studying how well testosterone gel works in preventing weakness caused by steroid therapy in men receiving glucocorticoids for newly diagnosed high-grade glioma.
Key facts
- Study ID
- NCT00631137
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- People needed
- 1
- Starts
- 2008-01-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2018-08-27
Who can join
Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.